Turning Hospitals Into Active Participants in Pharmaceutical Research
Today, data is one of the most valuable assets hospitals possess, with the global healthcare real-world data market estimated to be valued at $4 billion by 2030. Beyond improving patient care, this data can contribute to groundbreaking research, fuel advancements in medical science, and improve clinical outcomes. Healthcare data accounts for an estimated 30% of […]
Driving Clinical Innovation Through Real-World Data: Briya’s Strategic Collaboration with MSD
The future of healthcare is being reshaped by a wave of data-driven discovery, unleashing limitless potential for medical breakthroughs. With technology that enables unbounded access to vast, interconnected patient-level datasets, the healthcare industry is empowered to explore the complex fabric of human health in ways previously unimaginable. We’re now able to pull a needle from […]
5 Ways Real-Time Data is Revolutionizing Clinical Trials: Accelerating Research and Boosting ROI
Even though clinical trials are essential for gaining indispensable insights into treatments and obtaining regulatory approval for drug development, the administrative landscape of these trials proves to be challenging and difficult to navigate. With prevalent challenges such as patient recruitment and retention, increased complexity, and harsh regulatory hurdles, clinical trials often become extremely expensive and […]
New FDA Guidelines on Real-World Data: Implications for Healthcare Research and Innovation
The U.S. Food and Drug Administration (FDA) has recently released final guidance on the use of Real-World Data (RWD) in regulatory decision-making for drug and biological products. This landmark document, focusing on electronic health records (EHRs) and medical claims data, marks a significant step forward in the healthcare industry’s approach to drug development and approval […]
The Value of Briya’s Maternal Health Data
One way to address the shortcomings of maternal health care is by facilitating the proper utilization of patient data. As in most industries, the actual availability of data isn’t the problem: with the digitization of health records, prescriptions, and test results, HMOs and hospitals, in theory, sit on a wealth of data that encompasses nearly […]
